Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


14.10.2019

8 Antimicrob Agents Chemother
1 Int J Antimicrob Agents
4 J Antimicrob Chemother
1 J Clin Microbiol
1 Lancet Infect Dis
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. CLANCY CJ, Nguyen MH
    Estimating the size of the United States market for new antibiotics with activity against carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01733.
    PubMed     Text format     Abstract available

  2. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    PubMed     Text format     Abstract available

  3. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    PubMed     Text format     Abstract available

  4. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    PubMed     Text format     Abstract available

  5. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    PubMed     Text format     Abstract available

  6. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    PubMed     Text format     Abstract available

  7. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    PubMed     Text format     Abstract available

  8. FARRUKEE R, Zarebski AE, McCaw JM, Bloom JD, et al
    CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01081.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  9. WU D, Yan B, Yang X, Ji S, et al
    Whole-genome sequencing for the detection of linezolid resistance in a patient with persistent methicillin-resistant Staphylococcus aureus infection during linezolid exposure.
    Int J Antimicrob Agents. 2019 Oct 7. pii: S0924-8579(19)30274.
    PubMed     Text format    


    J Antimicrob Chemother

  10. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  14. WORKNEH M, Wang R, Kazmi AQ, Chambers KK, et al
    Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Re-evaluating Zone Diameter Cutoffs.
    J Clin Microbiol. 2019 Oct 9. pii: JCM.01127-19. doi: 10.1128/JCM.01127.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  15. ANDERSON M, Schulze K, Cassini A, Plachouras D, et al
    A governance framework for development and assessment of national action plans on antimicrobial resistance.
    Lancet Infect Dis. 2019 Oct 3. pii: S1473-3099(19)30415.
    PubMed     Text format     Abstract available


    PLoS One

  16. RASHIDI A, Zhu Z, Kaiser T, Manias DA, et al
    Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.
    PLoS One. 2019;14:e0223890.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: